Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 398,204 | 214,203 | 140,833 | 119,073 | 102,306 |
| Cost of Goods | 51,967 | 34,393 | 21,884 | 17,039 | 14,759 |
| Gross Profit | 346,237 | 179,810 | 118,949 | 102,034 | 87,547 |
| Operating Expenses | 260,392 | 78,365 | 67,448 | 60,770 | 56,483 |
| Operating Income | 86,812 | 101,838 | 52,385 | 41,303 | 31,823 |
| Other Income | 7,699 | 2,881 | 282 | 587 | 1,586 |
| Pre-tax Income | 94,511 | 104,719 | 52,667 | 41,890 | 33,409 |
| Income Tax | 23,101 | 21,640 | 13,185 | -33,093 | 1,534 |
| Net Income Continuous | 71,410 | 83,079 | 39,482 | 74,983 | 31,875 |
| Net Income | $71,410 | $83,079 | $39,482 | $74,983 | $31,875 |
| EPS Basic Total Ops | 0.67 | 0.80 | 0.38 | 0.72 | 0.31 |
| EPS Basic Continuous Ops | 0.67 | 0.80 | 0.38 | 0.72 | 0.31 |
| EPS Diluted Total Ops | 0.63 | 0.75 | 0.37 | 0.71 | 0.30 |
| EPS Diluted Continuous Ops | 0.63 | 0.75 | 0.37 | 0.71 | 0.30 |
| EPS Diluted Before Non-Recurring Items | 1.83 | 0.75 | 0.37 | 0.40 | 0.30 |
| EBITDA(a) | $119,693 | $103,077 | $52,577 | $41,395 | $32,122 |